MedTrace Logo

Characterization of Thyroid Nodules Using Contrast Enhanced Ultrasound

NCT01225016 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-01-31

No results posted yet for this study

Summary

This study will evaluate thyroid nodules using specialized ultrasound imaging methods.

Conditions

  • Thyroid Nodules

Interventions

DRUG

Definity contrast agent

Thyroid ultrasound using contrast agent

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Glenn E Peters, MD · University of Alabama at Birmingham

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01225016 on ClinicalTrials.gov